Dr. Roybal is an Assistant Professor in the Department of Microbiology and Immunology at the University of California, San Francisco. He is a full member of the Parker Institute for Cancer Immunotherapy and an inaugural Chan Zuckerberg Biohub investigator. He received a doctorate in Immunology from the University of Texas Southwestern Medical Center at Dallas in 2013. There he studied the fundamental cellular and biochemical mechanisms that regulate T cell activation at the system-scale using quantitative live cell fluorescent imaging in Christoph Wulfing's laboratory. Dr. Roybal then moved to Wendell Lim's lab at the University of California, San Francisco and the Howard Hughes Medical Institute as a Jane Coffin Childs Memorial Fund Postdoctoral Fellow. There he developed a new class of synthetic receptors called Synthetic Notch receptors that have far-reaching implications for cell therapies for cancer, autoimmunity, and regenerative medicine.